title: Second-line Treatment of Small Cell Lung Cancer: Is Platinum Sensitivity a Relevant Prognostic Factor?
authors.affiliation: Medical Oncology Unit, University Hospital, Parma, Italy. Electronic address: mtiseo@ao.pr.it.
authors.forename: Marcello
authors.initials: M
authors.lastname: Tiseo
authors.affiliation: Clinical Trials Coordinating Center, Istituto Toscano Tumori, University Hospital Careggi, Firenze, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Boni
authors.affiliation: Medical Oncology Unit, Sant'Orsola-Malpighi University Hospital, Bologna, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Ardizzoni
mesh_terms: D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D009944:Organoplatinum Compounds / Q000494:pharmacology*; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy*
chemical_list: D009944:Organoplatinum Compounds